Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism

Lung Cancer

Volumn 78, Issue 2, 2012, Pages 161-166

  Shinagare, Atul B ^a,b   Okajima, Yuka ^b   Oxnard, Geoffrey R ^b   DiPiro, Pamela J ^a,b   Johnson, Bruce E ^b   Hatabu, Hiroto ^b   Nishino, Mizuki ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lung cancer; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; PRIORITY JOURNAL; PULMONARY ARTERY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY EMBOLISM; RECURRENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VENOUS THROMBOEMBOLISM;

EID: 84867404638     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.08.007     Document Type: Article

References (28)

1. Lyman G.H., Khorana A.A. Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol 2009, 27(October (29)):4821-4826.
2. Gosselin M.V., Rubin G.D., Leung A.N., Huang J., Rizk N.W. Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. Radiology 1998, 208(July (1)):209-215.
3. Levine M., Hirsh J., Gent M., Arnold A., Warr D., Falanga A., et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994, 343(April (8902)):886-889.
4. Agnelli G., Gussoni G., Bianchini C., Verso M., Mandalà M., Cavanna L., et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 2009, 10(October (10)):943-949.
5. Perry J.R., Julian J.A., Laperriere N.J., Geerts W., Agnelli G., Rogers L.R., et al. PRODIGE a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost 2010, 8(September (9)):1959-1965.
6. Streiff M.B. Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J Clin Oncol 2009, 27(October (29)):4889-4894.
7. Coleman R., MacCallum P. Treatment and secondary prevention of venous thromboembolism in cancer. Br J Cancer 2010, 102(April (Suppl. 1)):S17-S23.
8. Kakkar A.K. Prevention of venous thromboembolism in the cancer surgical patient. J Clin Oncol 2009, 27(October (29)):4881-4884.
9. Shinagare A.B., Guo M., Hatabu H., Krajewski K.M., Andriole K., Van den Abbeele A.D., et al. Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer 2011, 117(August (16)):3860-3866.
10. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(October (5)):277-300.
11. Tesselaar M.E., Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007, 13(September (5)):362-367.
12. Tagalakis V., Levi D., Agulnik J.S., Cohen V., Kasymjanova G., Small D. High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. J Thorac Oncol 2007, 2(August (8)):729-734.
13. Chew H.K., Davies A.M., Wun T., Harvey D., Zhou H., White R.H. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008, 6(April (4)):601-608.
14. den Exter P.L., Hooijer J., Dekkers O.M., Huisman M.V. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011, 29(June (17)):2405-2409.
15. Gomes M.P.V., Deitcher S.R. Diagnosis of venous thromboembolic disease in cancer patients. Oncology (Williston Park, NY) 2003, 17(January (1)). 126-35, 139; [discussion 139-44].
16. Beasley M.B., Brambilla E., Travis W.D. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005, 40(April (2)):90-97.
17. Kearon C., Kahn S.R., Agnelli G., Goldhaber S., Raskob G.E., Comerota A.J. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133(June (Suppl. 6)):454S-545S.
18. Gladish G.W., Choe D.H., Marom E.M., Sabloff B.S., Broemeling L.D., Munden R.F. Incidental pulmonary emboli in oncology patients: prevalence CT evaluation, and natural history. Radiology 2006, 240(July (1)):246-255.
19. Douma R.A., Kok M.G.M., Verberne L.M., Kamphuisen P.W., Büller H.R. Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res 2010, 125(June (6)):e306-e309.
20. Browne A.M., Cronin C.G., English C., NiMhuircheartaigh J., Murphy J.M., Bruzzi J.F. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 2010, 5(June (6)):798-803.
21. Chew H.K., Wun T., Harvey D., Zhou H., White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006, 166(February (4)):458-464.
22. Sallah S., Wan J.Y., Nguyen N.P. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002, 87(April (4)):575-579.
23. Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007, 110(November (10)):2339-2346.
24. Blom J.W., Vanderschoot J.P.M., Oostindiër M.J., Osanto S., van der Meer F.J.M., Rosendaal F.R. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006, 4(March (3)):529-535.
25. Khorana A.A., Connolly G.C. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009, 27(October (29)):4839-4847.
26. Palla A., Rossi G., Falaschi F., Marconi L., Pistolesi M., Prandoni P. Is incidentally detected pulmonary embolism in cancer patients less severe? A case-control study. Cancer Investigation 2012, 30(February (2)):131-134.
27. Franklin J.M., Rahman N., Gleeson F.V. The clinician's response to a report of an incidental pulmonary embolism detected on multidetector CT. Postgrad Med J 2011, 87(November (1033)):746-749.
28. O'Connell C., Razavi P., Ghalichi M., Boyle S., Vasan S., Mark L., et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost 2011, 9(February (2)):305-311.